China Medical GatewayLoading your healthcare gateway…

Wang Xin

Wang Xin — Chief Physician — Breast Oncology — Tianjin Medical University Cancer Hospital

Specialties

Various radical surgeries for breast cancer, breast-conserving surgery, sentinel lymph node biopsy, minimally invasive surgery, and ductoscopy

Education

Graduated from Tianjin Medical University in 1991 with a bachelor's degree; graduated from Lund University in Sweden in 2001 with a Doctor of Medicine degree.

Professional Experience

Wang Xin, female, Deputy Chief Physician of the Department of Breast Tumors I, Associate Professor, Deputy Director of the Department of Breast I at Tianjin Cancer Hospital, and Doctor of Medicine. She is a New Century Talent of Tianjin Medical University, specializing in the early diagnosis of breast cancer, functional breast surgery, and personalized treatment. She is skilled in various radical breast cancer surgeries, breast-conserving surgery, sentinel lymph node biopsy, minimally invasive surgery, and ductoscopy. In 2007, she received the Third Prize of Tianjin Science and Technology Progress Award (Project: Anatomical Physiology of Intercostal Arm Nerve and Its Application in Functional Breast Surgery, 2007JB-3-164-R3). She has GCP qualification and is capable of leading clinical trials. She has completed the Tianjin Higher Education Science and Technology Development Fund Project on the correlation of CysLT1 and CysLT2 receptors with breast cancer, which has been evaluated for results. She undertakes the National Natural Science Foundation project on the mechanism by which tumor growth suppressor Rb regulates cell transformation by controlling energy metabolism balance (second principal investigator). She has been a guest speaker at the Northern Health Network Lecture Hall on "Interpretation and Prevention of Breast Cancer."

Professional Roles

Youth member of the Breast Cancer Professional Committee of the Anti-Cancer Association, editorial board member of the Chinese Journal of Cancer Prevention and Treatment, editorial board member of the English edition of Chinese Clinical Oncology.

Return to Home